Pharmaceutical compounds
US8101607B2 · kind B2 · utility
1Cited by
13References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2010 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Jul 13, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating diseases or disorders arising from abnormal cell growth, function or behavior associated with PI3 kinase, which method includes administering to a patient in need thereof a compound that is a fused pyrimidine of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.